Suchergebnisse - "Armuzzi, Alessandro"

PubPharm (427)

91

Ileal Pouch-Anal Anastomosis and Pouchitis : The Role of the Microbiota in the Pathogenesis and Therapy

enthalten in: Nutrients | 2022

von Gabbiadini, R. | Dal Buono, A. | Correale, C. | +4

92

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease : a multicentre, randomised, double-blind, parallel-group, phase 3b trial

enthalten in: Lancet (London, England) | 2022

von Sands, B. | Irving, P. | Hoops, T. | +117

CommentIn: Lancet. 2022 Jun 11;399(10342):2169-2171. - PMID 35691307

93

Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease : a systematic review and meta-analysis

enthalten in: BMC gastroenterology | 2022

von Peyrin-Biroulet, L. | Arkkila, P. | Armuzzi, A. | +13

94

Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis

enthalten in: BMC gastroenterology | 2022

von Peyrin-Biroulet, L. | Arkkila, P. | Armuzzi, A. | +13

95

Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis

enthalten in: BMC gastroenterology | 2022

von Peyrin-Biroulet, L. | Arkkila, P. | Armuzzi, A. | +13

96

Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies : Randomized SERENE CD Trial Results

enthalten in: Gastroenterology | 2022

von D'Haens, G. | Sandborn, W. | Loftus, E. | +19

CommentIn: Gastroenterology. 2022 Jun;162(7):1831-1832. - PMID 35364063

97

Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Pugliese, D. | Privitera, G. | Schepis, T. | +6

98

Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis : SERENE UC Trial Results

enthalten in: Gastroenterology | 2022

von Panés, J. | Colombel, J. | D'Haens, G. | +25

99

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis : IG-IBD technical review based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Bonovas, S. | Pansieri, C. | Piovani, D. | +6

100

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis : IG-IBD clinical guidelines based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Macaluso, F. | Orlando, A. | Papi, C. | +55